# Ventana Biotech, Inc. (VNTA)

> Financial Services · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VNTA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 117.3K | $ 88.2K | N/A | $ 113.1K | $ -53.9K |
| 2024 | $ 43.5K | $ 20.9K | N/A | $ 109.6K | $ -52.3K |
| 2023 | $ 32.9K | $ 18.7K | $ 1.8K | $ 105.1K | $ -72.2K |
| 2021 | $ 0 | $ -103.6K | N/A | N/A | N/A |
| 2020 | $ 0 | $ -20.0K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -2.10 |
| Liabilities / Eq | -2.13 |
| Current Ratio | 0.53 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 134.67 |
| Gross Debt / FCF | 62.85 |

## Other views

- [Metrics](https://sponda.capital/en/VNTA.md)
- [Charts](https://sponda.capital/en/VNTA/charts.md)
- [Compare](https://sponda.capital/en/VNTA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.